Dexamethasone / Prednisolone

DRUG4 trials

Sponsors

Goethe University, Johann Wolfgang Goethe University Hospital

Conditions

Adult Acute Lymphocytic Leukemia

Phase 4

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93)

CompletedNCT00199069

Goethe UniversityAdult Acute Lymphocytic Leukemia

Start: 1993-04-30End: 2001-05-31Target: 720Updated: 2023-03-17

German Multicenter Trial for Treatment of Elderly Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

CompletedNCT00198978

Goethe UniversityAdult Acute Lymphocytic Leukemia

Start: 2003-01-31End: 2014-06-30Updated: 2023-03-20

German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (06/99)

CompletedNCT00199056

Goethe UniversityAdult Acute Lymphocytic Leukemia

Start: 1999-10-31End: 2005-12-31Target: 225Updated: 2023-03-20

Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab

CompletedNCT00199004

Johann Wolfgang Goethe University HospitalAdult Acute Lymphocytic Leukemia

Start: 2004-04-30End: 2009-03-31Target: 60Updated: 2010-08-23

Related Papers

S114: OUTCOME OF OLDER PATIENTS (>55 YRS) WITH NEWLY DIAGNOSED PH/BCR:ABL POSITIVE ALL PROSPECTIVELY TREATED ACCORDING TO PEDIATRIC-BASED, AGE-ADAPTED GMALL PROTOCOLS

HemaSphere2023-08-01

Outcome of 841 Older Patients (&gt;55 yrs) with Newly Diagnosed Ph/BCR-ABL Negative ALL Prospectively Treated According to Pediatric-Based, Age-Adapted GMALL Protocols

Blood2022-11-1516 citations

Adults with Philadelphia chromosome–like acute lymphoblastic leukemia frequently have <i>IGH-CRLF2</i> and <i>JAK2</i> mutations, persistence of minimal residual disease and poor prognosis

Haematologica2016-08-25161 citations

Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL.

2012-09-28342 citations

Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies.

2012-03-22349 citations